Retrospective study of apremilast drug survival in psoriasis patients in a daily practice setting: A long‐term experience-Reference-Cited by-同舟云学术

Retrospective study of apremilast drug survival in psoriasis patients in a daily practice setting: A long‐term experience

Published:2022-05-24 Issue:7 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Galache‐Osuna Cristina¹²^ORCID,Reyes‐García Sebastián¹,Salgueiro Esther²³^ORCID,Bordallo‐Landa Javier²³,Lozano Ana⁴^ORCID,Vázquez‐López Francisco¹²⁵,Santos‐Juanes Jorge¹²³⁵⁶^ORCID

Affiliation:

1. Dermatology Department of Hospital Universitario Central de Asturias Oviedo Asturias Spain

2. Grider. Grupo de Investigación en Dermatología Universidad de Oviedo Oviedo Asturias Spain

3. Area de Farmacologia. Departmento de Medicina University of Oviedo Oviedo Asturias Spain

4. Unidad de Gestión Clínica de Farmacia Hospital Universitario Central de Asturias Oviedo Asturias Spain

5. Área de Dermatología, Departamento de Medicina Universidad de Oviedo Oviedo Asturias Spain

6. Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) Instituto Universitario Oncológico del Principado de Asturias (IUOPA) Oviedo Asturias Spain

Publisher

Hindawi Limited

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15583

Reference28 articles.

1. The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios

2. Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis

3. Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Psoriasis Patients from the PsoBioTeq Cohort

4. Real‐world drug survival and reasons for treatment discontinuation of biologics and apremilast in patients with psoriasis in an academic center

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Four‐year drug survival of apremilast in patients with psoriasis;The Journal of Dermatology;2023-03-20